Antimicrobial Agents and Chemotherapy · 2018 · 31 citations · 16 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance GeneticsAntibiotic Resistance MechanismsBacterial InfectionsResistance SurveillanceCephalosporin ResistanceCephalosporin TherapyMethicillin ResistanceMethicillin-resistant Staphylococcus Aureus SurveillancePenicillin-binding Protein AlterationsResistance ClonesResistance Mechanisms In StaphylococciTherapeutic Failure
Ceftobiprole is a fifth-generation cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA). One-year surveillance at the Regional Hospital of Ancona (Italy) disclosed a 12% ceftobiprole resistance rate (12/102 isolates; MIC, ≥4 mg/liter).
16
Mark C. Enright, Nicholas Day, Catrin E. Davies et al. · Journal of Clinical Microbiology · 2000 · 3K citations · Full text
Susan Boyle‐Vavra, Ben Ereshefsky, Chih‐Chien Wang et al. · Journal of Clinical Microbiology · 2005 · 278 citations · Full text
Todd A. Davies, Malcolm G. P. Page, Wenchi Shang et al. · Antimicrobial Agents and Chemotherapy · 2007 · 162 citations · Full text